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Introduction 
Gene expression in an eukaryotic cell 
Transcription 
A gene is encoded by a specific sequence in the DNA. This sequence must be 
transcribed into RNA and further processed to become the protein structure that 
it has to. The transcription from DNA into RNA copies is done by an enzyme 
called polymerase. This enzyme adds the complementary bases of the DNA 
sequence next to each other and in this way creates a complementary strand. 
This strand is complementary to the 3´- 5´DNA template strand, which is 
complementary to the 5´- 3´coding DNA strand. Thus the transcribed RNA 
strand is identical with the coding DNA strand, the only exception is that all 
thymines are replaced by uracils in the RNA sequence. 
(Brueckner, Armache et al. 2009) 
The result of this transcription process is the so called messenger RNA 
(mRNA). This mRNA is necessary to produce a protein via translation.  
The sequence that results after transcription contains so called regulatory 
sequences which are necessary for direction and regulation of the synthesis of 
the protein. These non coding sequences are upstream the coding region (five 
prime untranslated region – 5 ´UTR) or downstream the coding region (three 
prime untranslated region – 3´UTR). 
Only one of the two complementary DNA strands, the so called template strand, 
is transcribed. The other strand is called coding strand, because it has the same 
sequence like the new transcribed RNA. Contrary to the DNA replication, there 
are no Okazaki fragments needed in the transcription process because only the 
3 ´- 5 ´ sequence is used. (Brueckner, Armache et al. 2009) 
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Post-transcriptional modifications 
The primary RNA transcript consists of coding regions, so called exons and non 
coding regions, so called introns. In the process of RNA maturation, the introns 
are cut out of the primary sequence. This process is called splicing. After 
cutting, the exons are tight together. 
In the process of maturation the RNA undergoes three specific modifications : 
• 5 ´capping 
• 3´polyadenylation 
• RNA splicing 
All of these three modifications occur in the nucleus of the eukaryotic cell after 
transcription but before the RNA is translated. (Riccardo, Tortoriello et al. 2007) 
 
5´Capping:  
A phosphatase Enzyme removes the terminal 5´phosphate, so that a 7-
methylguanosine (m7G) can be added to the 5´end. The enzyme guanosyl 
transferase produces a diphosphat 5´end. This diphosphat end attacks the α 
phosphorus atom of the Guanosintriphosphat (GTP) complex and in this way 
adds a guanine residue in a 5´5´triphosphate link. An enzyme called S-adenosyl 
methionine methylates the guanine ring at the N-7 position. This cap is called 
the cap 0 structure, because it has only got the (m7G) in position. For a cap 1 
structure, the ribose of the next nucleotide has to be methylated too. When the 
methylation continues downstream, cap 2, 3 etc. These caps have the ability to 
protect the primary RNA transcript from ribonucleases. The methyl groups that 
are necessary to form the cap structure are added to the 2´OH groups of the 
ribose sugar. (Riccardo, Tortoriello et al. 2007) 
 
3´Polyadenylation: 
For a polyadenylation of the 3´end of the RNA tail a polyadenylation signal 
sequence (5´- AAUAAA – 3´) is needed. This signal sequence is usually located 
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near the 3´end of the pre-mRNA and followed by another sequence which is 
usually (5´ - CA - 3´). The second sequence is the signal site for cleavage, 
whereas further downstream the RNA tail a GU rich fragment is usually present 
in pre mRNAs. (Alberts, Bray et al. 2005) 
Later on the RNA Polymerase2 enzyme transfers the Cleavage and 
Polyadenylation Specificity Factor (CPSF) and the Cleavage Stimulation Factor 
(CStF) to the RNA molecule. Together they form a complex that cleaves the 
RNA tail between the polyadenylation site and the GU rich sequence, at the 
cleavage site (5´-CA-3´). (Alberts, Johnson et al. 2002) 
Another enzyme, called Poly(A)polymerase, adds up to 200 adenines to the 
new 3´end of the RNA tail. The needed substrate for this process is ATP, which 
serves as a precursor. Thus the 3´ RNA end is protected from nuclease 
digestion by the Poly-A-tail. (Alberts, Johnson et al. 2002) 
 
Splicing:  
In the RNA splicing process, the introns, which are the non coding regions, are 
removed from the pre-mRNA. These introns do not code for any protein but are 
sometimes used to process small RNAs like non coding RNAs. After the 
process of splicing the RNA molecule consists only of exons. The process of 
splicing is catalyzed by the so called Spliceosome, which is a complex of 
specialized small nuclear RNAs and proteins. These small RNA molecules 
recognize splice sites in the pre-mRNA sequence, so that the process of 
splicing can start. (Alberts, Bray et al. 2005) 
A lot of pre-mRNAs can be spliced in different ways and furthermore encode for 
different proteins, depending on the process of splicing. This ability to splice one 
pre-mRNA in different ways and produce different proteins is called alternative 
splicing. This process gives the facility to produce a range of different proteins 
from a limited number of DNA and belongs to the post-transcriptional 
modifications. (Alberts, Johnson et al. 2002) 
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microRNA  
micro RNAs (miR) are small non coding RNAs of about 18-24 nucleotides 
length.  
 
Figure  1 miRNA Function (Nelson, Baldwin et al. 2003) 
miRs effect the gene expression after  transcription. For this regulation they use 
evolutionary ancient mechanisms.  They have the ability to “cleave” to their 
target-mRNA and in this way block the translation or they elicit target mRNA 
degradation. Furthermore the mRNA cannot be translated into the protein 
structure and degrades. This process is also a post-transcriptional modification, 
with the effect that the protein is not built and the cellular response is changed. 
Just like other RNAs, miR sequences are anchored in the DNA and get 
transcribed. This transcription includes stem-loop precursors and build up the 
precursor miR, including the miR itself. The first processing step inside the 
nucleus is done by the RNase Drosha. Afterwards the precursor miR gets 
exported into the cytoplasm, where the RNase Dicer is responsible for further 
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processing the structure. Furthermore the miR binds to a protein complex, 
called Argonaute-family, this newly synthesized structure is called RNA-induced 
silencing complex (RISC) and enables the miR to work. (System Biosciences) 
miRs used in this Thesis 
• miR7i 
The importance of TLRs will be described in another chapter. MiR7i seems to 
have an influence on the expression of TLR 4, which is responsible for LPS 
signaling. The TLR 4 expression level is degraded in CACO2 cells, maybe 
because of the adaptation processes, which are necessary in the gut. Chen et 
al. already showed in 2007 that the miR7i directly regulates the expression of 
TLR4, in the way of blocking expression through mRNA translational 
repression.  
(Chen, Splinter et al. 2007) 
• miR27b 
Jennewein et al. claimed 2009 that miR 27b destabilizes PPARγ mRNA in 
macrophages after LPS treatment. PPARγ is well known because of its anti-
inflammatory effects. The activation of PPARγ is very interesting and important 
for the field of cronic inflammatory diseases. (Jennewein, Knethen et al. 2010) 
• miR155 
Tili et al. reported in 2007 that miR155 plays an important role in innate 
immunity. They showed that miR155 targets some transcripts coding for 
proteins that are necessary in the LPS signaling pathway such as IκB.  
(Tili, Michaille et al. 2007) 
O´Connell et al. also showed a miR155 responsiveness to LPS and an 
increased miR155 level in patients with acute myeloid leukemia. Furthermore, 
O´Connell et al. conclude that miR155 is a common target for a broad range of 
inflammatory mediators. (O’Connell, Taganov et al. 2006)  
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O´Connell et al. found that miR155 is involved in the first line of defense in 
macrophages, in response to different types of inflammatory mediators. This 
fact ensures an important role for miR155 in cancer development and innate 
immunity. (Connell, Rao et al. 2008) 
 
RNA export 
Most mature RNAs must be transported out of the nucleus to be further 
processed. These mature RNAs often use nuclear pores for the export into the 
cytosol. In this case, the RNA is an information carrier for the protein synthesis 
and it is called mRNA. (Anfinsen 1972)  
 
Translation 
For non-coding RNAs, the RNA construct is the finished product. Contrary, most 
of the RNA in the cell encodes for one or more proteins (mRNA). In the coding 
regions of the RNA sequence, each triplet of nucleotides corresponds to a 
binding site of the so called transfer RNA (tRNA). Later on this transfer RNA is 
translated into amino acids which are chained together by ribosomes. Thus the 
sequence of the tRNA becomes a protein. Where in the cell the protein 
synthesis takes place, depends on where the protein is needed. It can for 
example be formed in the cytoplasm or the endoplasmatic reticulum. (Alberts, 
Johnson et al. 2002)  
 
Folding 
After Translation proteins are unfolded polypeptides, so called random coils, 
when translated from a mRNA to a linear chain of amino acids. For the right 
function of a protein, it has to be folded specifically. Amino acids interact with 
each other to reach the specific 3 dimensional structure. Thus it seems clear 
that the specific 3D structure of the protein depends on the amino acid 
sequence. 
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A mistake in folding can lead to inactive proteins with different properties such 
as toxic prions or cause neurodegenerative and other diseases. (Anfinsen 
1972) 
The process of folding can already start during translation, in this case the N-
terminus of the protein, which is translated first, starts to fold while the C-
terminus is still in the translation phase. Chaperons, which are protein 
structures that appear during folding, but do not occur in the product, assist in 
the folding procedure of other proteins. These chaperons are commonly known 
as Heat Shock Proteins (HSP) whose expression is elevated when the 
temperature in the cell raises or other environmental stress situations disturb 
the cell. (Alberts, Johnson et al. 2002) 
 
Protein transport 
In some cases the produced proteins are not targeted for the places where they 
were produced. They have to be transported to their target location. For this 
transport system a wide range of signaling sequences are necessary, to lead 
the protein into the right direction.  
A variety of proteins which are produced for extracellular mechanisms is 
exported out of the cell. Such proteins are for example: digestive enzymes, 
hormones or extracellular matrix proteins. In eukaryotes, most of the transports 
are done through translocation to the endoplasmatic reticulum and further to the 
Golgi apparatus, from where the export is completed. (Anfinsen 1972) 
 
Signaling 
Cell signaling is necessary for coordination of the functions in the cell and the 
communication that governs basic cellular activities. This ability to respond to 
environmental influences provides the cell´s basis for development, tissue 
repair, immunity and homeostasis. Cancer, autoimmune diseases and diabetes 
Introduction |21 
 
can occur because of errors in this complex signaling system. (LinkWitzany 
2010 ) 
The way of information transport is a complex signaling network. Changes in 
this network can influence transmission and flow of information. (Brueckner, 
Armache et al. 2009) 
Cells can communicate with each other using the following ways:  
• Juxtacrine signaling – means transport over direct contact 
o Information is transmitted through oligosaccharides, lipids 
or protein components 
• Paracrine signaling – means transport over short distances  
o Information is transmitted over short scales because the 
information carrier degrade very early on their way. One 
example are growth factors. 
• Endocrine signaling – means transport over large distances 
o Information is transmitted for example via hormones in the 
blood over large scales. (Brueckner, Armache et al. 2009) 
 
Signaling pathways 
Signaling pathways in the cell are possibilities for the cell to respond to 
environmental influences. The first step in this system is a protein complex 
called receptor. These receptors are often located at the cell surface and are 
able to stimulate specific interactions of protein structures which are activated or 
deactivated by mechanisms like phosphorylation, ubiquitination, etc. Depending 
on the ligand that binds to the receptor, the specific receptor can initiate a range 
of pathways. A cell-surface-receptor is necessary because these ligands are 
mostly hydrophilic and thus cannot pass the cell membrane. In some cases 
receptors are also located in the cytosol or at the nucleus, the so called nuclear-
receptors. One of them is Peroxisome Proliferator Activated Receptor γ 
(PPARγ) which will be discussed later in this work. Which ligand is activated 
and further binds to its receptor depends on the environmental exposure. There 
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are specific ligands and receptors for inflammatory and anti-inflammatory 
processes, called cytokines that will be the main theme in this ongoing work. 
Taken together there are three classes of cell-surface-receptors: 
• Ion-channel receptor: opens and closes after binding of a signal 
molecule 
• G-protein-coupled receptor: binds to an extracellular signal 
molecule and first transmits the signal to a GTP-binding protein 
which is bound to the receptor. Furthermore, this activated G-
protein leaves its receptor and activates an enzyme or a Ion-
channel in the plasma membrane. The so called G-protein is a 
complex of three subunits, which can dissociate from each other 
in response to a signal. 
• Enzyme-coupled receptor: if a signal molecule binds to this sort of 
receptor, the enzyme inside the cell is activated. This activation 
can be limited to its own activity or also take other enzymes into 
account. (Alberts, Bray et al. 2005) 
These three types of receptors differ in their intracellular signals. In the case of 
Ion-channel receptors, the intracellular response to the binding of a signal 
molecule is the flowing of ions through the membrane. This flow produces 
electrical energy. G-protein coupled receptors activate a class of membrane 
bound proteins, so called G-proteins, which further can move in the plasma 
membrane and initiate a cascade of other effects. When the an enzyme-
coupled receptor or a coupled enzyme is activated, additional signals are 
initiated, including small molecules which are released in the cytosol of the 
eukaryotic cell. (Alberts, Bray et al. 2005) 
The number of receptor-types is even larger than the number of extracellular 
signals. This is because one extracellular signal molecule is able to bind to 
more than one receptor. In some cases, extracellular signals bind to different 
receptor-types in different tissues. This enables tissues to respond in different 
ways to the same signal molecule. (Alberts, Bray et al. 2005) 
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The discussed extracellular receptors can also bind to substances like heroin, 
nicotin, tranquilizers and chilipepper. These substances either act like natural 
ligands and initiate a physiological signal transduction or they bind onto different 
sites of the receptor and thereby block or over-stimulate the receptor activity. A 
lot of pharmaceuticals also affect these receptors to initiate the response of 
choice. (Alberts, Bray et al. 2005) 
 
Enzyme coupled Receptors 
Enzyme coupled receptors are transmembrane proteins and their ligand binding 
domain is directed outside the plasma membrane. This type of receptors 
responds to signals which control cellular differentiation, growth, proliferation 
and survival. Mistakes in these mechanisms can lead to the development of 
cancer. In this work mediators and signal transducers that aim at least one of 
these processes will be discussed. 
Most of the signal molecules act as local mediators and initiate their effect even 
in low concentrations. The response to these mediators typically takes a few 
hours because a complex intracellular signaling cascade is needed. Finally the 
gene expression is changed. 
The main types of these enymze coupled receptors are those which have a 
cytoplasmatic domain, working as tyrosine-proteinkinase. This kinase is able to 
phosphorylate tyrosin at the sidechains of specific proteins inside the cell. 
These receptors are called receptor-tyrosine-kinases. (Alberts, Bray et al. 2005) 
Scientists suggest that the enzyme coupled receptor protein consists of only 
one transmembrane segment which passes through the membrane in an α-helix 
structure. The kinase function is often activated by dimerisation. Thus, one 
receptor is able to phosphorylate the other. In the case of receptor-tyrosin-
kinases, the phosphorylation takes place on a tyrosin-rest. After 
phosphorylation a complex signal transduction cascade begins. 
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The phosphorylated tyrosines serve as binding sites for 10-20 intracellular 
signaling proteins, which can be activated by this binding situation. As long as 
this complex exists, it sends signals over a wide range of possible ways with 
completely different aims at the same time. Furthermore a lot of biochemical 
changes appear in these pathways which are necessary to initiate  such 
complex procedures like cell proliferation. To stop the process of receptor 
activation, protein-tyrosine-phosphatases are necessary. These enzymes cut 
the phosphates off again and in this way stop the activation. In some cases the 
activated receptors are digested in lysozymes after endocytosis.  
Different receptor-tyrosine-kinases have different intracellular signaling proteins 
for different outcomes. Nevertheless, some seem to be more important than 
others and are used more often. One example is the phospholipase which is 
necessary for the activation of the inositiolphospholipid-signaling way. 
Receptor-tyrosine-kinases are also able to activate an important enzyme in 
signal-transduction, called phosphatidylinositol-3-kinase, which phosphorylates 
inositolphospholipids in the plasmamembrane.  
The main signaling way of receptor-tyrosine-kinsases is a different one than that 
described above. Uncontrolled mutations that activate this signaling cascade 
lead to the development of a lot of cancers through stimulation of cell division. 
(Alberts, Bray et al. 2005) 
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The way from the Receptor to the Nucleus 
Some of the signaling proteins are just used as adaptor molecules in the 
signaling process. This means that they help to build up a signaling aggregate 
through binding the receptor to other proteins, which are activated and transport 
the signal further on. An important role in this complex is hosted by the Ras 
protein. This protein is located tightly to the plasma membrane by a lipid 
structure. Nearly all receptor-tyrosine-kinases activate the Ras protein. 
 
The Ras Protein 
The Ras protein belongs to the family of GTP-binding proteins, but they only 
form monomers in contrast to the trimer-G-Proteins. Ras has a similar structure 
to the α subunit of a G-Protein and functions as a molecular switch. Ras is 
activated by binding of GTP and changes its confirmation status. Through 
hydrolysis of GTP to Guanosindiphosphat (GDP), Ras turns itself off again. 
When Ras is activated it initiates a phosphorylation cascade that is defined by 
phosphorylation of proteinkinases. These kinases phosphorylate each other in 
the ongoing cascade. This way of phosphorylation and signal transduction is 
called MAP-Kinase-Cascade because the last kinase in the pathway is called 
Mitogen Activated Protein Kinase (MAP-Kinase). Within the signal transduction 
pathway, the MAP-Kinase is phosphorylated and thereby activated by an 
enzyme called MAP-Kinase-Kinase. This enzyme itself is activated by a MAP-
Kinase-Kinase-Kinase, which is activated by Ras. At the end of the pathway 
MAP-Kinase phosphorylates serines and threonines on specific gene regulatory 
proteins and thereby changes their ability to regulate the expression of genes. 
Depending on which other signals the cell receives and which other genes are 
active in the cell, this signaling cascade can influence the gene expression, 
stimulate the cell proliferation, initiate cell survival or induce cell differentiation.  
When Ras is deactivated by intracellular injections of antibodies, the cell looses 
the ability to respond to several extracellular signals. If, on the other hand, the 
Introduction |26 
 
Ras activity is turned on over a period, the cell behaves as if it is treated with 
proliferation stimulating mitogens.  
In 30% of all human cancer types, the gene coding for Ras is mutated. in other 
types of cancer, often genes involved in the same pathway are affected. The 
wilde type of these genes, which is necessary for a “normal” function of a cell, is 
often called proto-oncogenes, because they can easily be turned into 
oncogenes by mutation. This is the start of the uncontrolled growth and division 
of cancer cells. (Alberts, Bray et al. 2005) 
 
The fast Way to the Nucleus 
Some hormones and a lot of local mediators, so called cytokines, bind to 
receptors that can activate generegulatory proteins, which are near the 
membrane in a latent state. Once activated, these regulator proteins aim the 
nucleus and stimulate the transcription of specific genes. Interferones are one 
popular example for this pathway. They are cytokines which make cells produce 
the proteins they need for the defense against viral infections.  
Cytokine-receptors do not have any enzyme activity like receptor-tyrosine-
kinases have. Instead, cytokine-receptors are bound to tyrosine-kinsases called 
Janus-Kinases (JAKs) which are activated in the case of cytokine binding to the 
receptor. When the JAKs are activated, they phosphorylate and activate 
cytoplasmatic generegulatory proteins, so called signal transducer and 
activators of transcription (STATs). These STATs move to the nucleus and 
stimulate the transcription of specific genes. 
Different cytokine receptors stimulate different responses, by activating different 
STATs. The cytokine signaling gets deactivated by proteinphosphatases, these 
phosphatases remove the phosphate groups from the activated signaling 
proteins. 
Another class of fast receptors are the receptor-serin/threonin-kinases. They 
directly phosphorylate and activate cytoplasmatic generegulatory proteins after 
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stimulation by an extracellular signaling molecule. The hormones and local 
mediators that stimulate this kind of receptors belong to the Tumor Growth 
Factor (TGF)-β-superfamily of extracellular proteins, which have an important 
role in the development of oncogenic transformation. (Alberts, Bray et al. 2005) 
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Figure  2 Signaling ways (Alberts, Bray et al. 2005) 
Signaling ways are often tight to each other. The picture shows the signaling 
ways of G-protein coupled receptors and enzyme coupled receptors, both 
acting at least in one possible pathway over phospholipase C. The involved 
protein kinases phosphorylate a lot of proteins, including those proteins that 
belong to other pathways. The red arrows show the tight network of regulatory 
links. (Alberts, Bray et al. 2005) 
 
Protein kinases are present in every signaling pathway. Through their 
overlapping phosphorylation they link different pathways to each other and build 
up a complex network. The single components of this network interact with each 
other, so that in fact nearly all control systems in the cell communicate with 
each other. Scientists believe that nearly 2% of all human genes encode for 
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protein kinases and that in a single eukaryotic cell hundreds of different protein 
kinases can be present. 
When an extracellular signal stimulates the cell, a lot of further mechanisms are 
possible, for example differentiation, growth, settlement, division and so on. 
Intracellular signaling proteins are often responsible for the response of a cell to 
the different extracellular information. These “conclusion-proteins” have different 
potential phosphorylation sites and each one of them can be phosphorylated by 
a different protein kinase. In this way different signals are summarized and 
produce one common response in the ongoing pathway. 
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Figure  3 Signaling Conclusion (Alberts, Bray et al. 2005) 
Signals A and B are able to activate different protein phosphorylating cascades, 
everyone of them leads to a phosphorylation of protein Y. But the 
phosphorylation happens on different sites of the protein. Protein Y is active 
when both sites are phosphorylated, furthermore the only possibility to activate 
protein Y is when both signals (A+B) appear at the same time. (Alberts, Bray et 
al. 2005) 
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Figure  4 An alternative way (Alberts, Bray et al. 2005) 
An alternative way for the signals A and B is the phosphorylation of the proteins 
X and Z. After phosphorylation of these proteins they can bind to each other and 
form the active heterodimere proteincomplex XZ. (Alberts, Bray et al. 2005) 
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Toll Like Receptors (TLR) 
To initiate a signaling pathway, an extracellular signal has to bind to a receptor,. 
One important and popular family of receptors in the inflammatory network are 
TLRs. TLRs are transmembrane proteins which have the ability to recognize 
invading microbes and initiate a signaling machinery inside the cell, producing 
immune and inflammatory responses to destroy the “enemies”. At the moment, 
eleven members of the TLR family are identified, TLR1-TLR11. The structure of 
the TLRs shows an extracellular domain, a transmembrane region and a 
cytoplasmatic tail. This cytoplasmatic tail is called the TIR (Toll-IL-
1R[Interleukin-1-Receptor]) homology domain. For an activation of a TLR, the 
cognate ligand must bind to the receptor. Different TLRs have different ligands 
for activation, ranging from bacterial cell wall components, viral double-stranded 
RNA to small molecule anti-viral or immunomodulatory compounds. After 
activation of TLRs, there are two possible pathways that can be initiated: 
1. The core pathway: most TLRs act through this pathway, it leads to an 
activation of Nuclear Factor kappa B (NFκB) and the MAPKs p38 and 
JNK (c-Jun-kinase).  
2. The second pathway: is activated by TLR3 and TLR4 and activates NFκB 
and Interferon Regulatory Factor-3 (IRF3), this enables the induction of 
an additional set of genes, like antiviral genes. 
There is a difference between TLRs located at the cell surface and those TLRs 
that are located on the endosome. Membrane bound TLRs are: TLR1, TLR2, 
TLR4, TLR5, TLR6 and TLR10. Intracellular TLRs are: TLR3, TLR7, TLR8 and 
TLR9. The newly discovered TLRs 11, 12 and 13 seem to belong to the group 
of intracellular TLRs. (Beutler 2004) 
 
Toll like Receptor 4 
This receptor is activated by Lipopolysaccharides (LPS), which are components 
of the cell surface of gram-negative bacteria, and Lipotechoic Acid (LTA). Both 
of these substances first bind to the Cluster of Differentiation 14 (CD14) 
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receptor, which transports the signal to the TLR4. Whereas LTA binds directly 
to the CD14 receptor, LPS must be transported by a LPS-binding-protein (LBP). 
The activation of TLR4 leads to a dimerization of the receptor, which further 
builds up a complex with the protein MD2, afterwards this complex is 
transported to the cell surface. The activation of TLR4 includes numerous  
Myeloid Differentiaion Primary-Response Proetin-88 (MyD88) adaptor family 
members. (Nishiya and DeFranco 2004) 
Over a complex signaling process, a lot of proteins are activated through 
phosphorylation and complexing mechanisms. This activation-pathway includes 
the activation of: Interleukin-1-Receptor Associated Kinase-1 (IRAK1), IRAK4 
Serine/Threonine Kinases, Tumor Necrosis Factor Associated Receptor Factor-
6 (TRAF-6), TGF-Beta-Activated Kinase-1 (TAK1), TAK1-Binding-Protein 
(TAB1), TAK2-Binding Protein (TAB2), Ubiquitin-Conjugating-Enzyme 13 
(UbC13), Ubiquitin-Conjugating-Enzyme E2-Variant-1 (UEV1A), Evolutionary 
Conserved Signaling Intermediate in Toll Pathways (ECSIT). (Beutler 2004) 
TAK1 also phosphorylates the Inhibitor of Kappa Light Polypeptide Gene 
Enhancer in B-Cells Kinase (IKK) complex, this complex consists of IKKα, IKKβ 
and IKKγ. Furthermore this IKK complex phosphorylates IκB, leading to an 
ubiquitylation and degradation of IκB. NFκB is not inhibited by IκB anymore and 
able to translocate to the nucleus and induce the expression of its target genes. 
(Yamamoto and Akira 2004) 
 
Toll like Receptor 2 
The TLR2 is activated by bacterial Lipoarabinomannan (LAM), bacterial 
Lipoprotein (BLP) and Peptidoglycans (PGN). It is also responsible for the 
recognition of yeast cell wall particles. cPGN and LAM interact with the TLR2 
over CD14, initiating a similar downstream signaling like the already discussed 
signaling after TLR4 stimulation. After stimulation by BLP, the TLR2 cascade 
leads to an activation of apoptosis as well as to an activation of NFκB. When the 
yeast cell wall particle Zymosan binds to CD14 and is transported to TLR2, the 
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production of Tumor Necrosis Factor (TNF) through the NFκB pathway is 
increased by a signaling mechanism. (Hallman, Ramet et al. 2001) 
 
Toll like Receptor 9 
This receptor recognizes CpG islands in the bacterial DNA. The mechanism is 
not really clear at the moment. Possible reactions are:  
• TLR9 is activated by extracellular bacterial CpG islands, leading to the 
endocytosis of these particles.  
• The other theory is that the bacteria are phagocytized and the TLR9, 
which has separately formed in the phagosome, is activated by the CpG 
islands. Afterwards TLR9 initiates a signaling pathway which stimulates 
NFκB. (Hallman, Ramet et al. 2001) 
Taken together, TLRs are responsible for the recognition of a range of 
extracellular signals, leading to an activation of immune- or inflammation 
specific genes. The TLR system is not fully understood at the moment and it 
seems as if not all TLRs are already identified. Animal models show new 
interesting TLRs, which have to be verified and also shown in the human model. 
Anyway the importance of TLRs is undisputed. (Cook, Pisetsky et al. 2002) 
 
Interleukin 6 (IL6) Signaling  
IL6 is a cytokine that is able to initiate several pathways responsible for 
inflammation, hematopoesis and oncogenesis by regulation of cell growth, gene 
activation, proliferation, survival and differentiation. When IL6 binds to its 
receptor, the recptor dimerizes. The Janus Kinase (JAK kinase) is activated, 
followed by activation of Ras-mediated signaling. The activated JAK 
phosphorylates and in this way activates STAT, STAT3 in particular. 
Furthermore STAT3 forms a dimer and translocates into the nucleus, where it 
promotes the expression of genes containing the STAT3 response elements. 
The Ras-mediated components of the pathway (named SHC, Growth Factor 
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Receptor Bound Protein 2 (GRB2) and Son of Sevenless 1 (SOS)) activate 
MAP-Kinases downstream followed by activation of transcription factors. These 
factors are involved in a range of different signaling pathways and regulate a lot 
of complex promoters and enhancers that are activated in the IL6 and other 
signaling pathways. (Heinrich, Behrmann et al. 1998) 
In its signaling pathway IL6 also activates Phosphoinositide-3-Kinase (PI3K), 
which functions in a cascade of PI3K/Akt/Nuclear Factor `kappa-light-chain-
enhancer` of activated B-cells and promotes the most effective anti-apoptotic 
characteristics of IL6 against the Transforming Growth Factor-Beta (TGFβ). 
(Heinrich, Behrmann et al. 1998) 
 
Figure  5 IL6 Signaling  
Internet:http://www.sabiosciences.com/pathway.php?sn=IL-6_Pathway (accessed 6. March 
2010)  
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Tumor Necrosis Factor α (TNFα) Signaling 
Active TNFα binds to the TNF receptor, initiating the transduction of growth 
regulatory signals into the cell. It furthermore starts programmed cell death and 
apoptosis in transformed cells, followed by DNA fragmentation and cytolysis. 
The so called Death Domain is a protein-protein complex which is necessary to 
transport the apoptotic signals. TNFα is also able to mediate a survival pathway 
via NFκB, for this pathway a phosphorylation of IκB is necessary, because this 
enables NFκB to dissociate from the inhibitory complex and act as a 
transcription factor in the nucleus. Cells in which the NFκB signaling pathway is 
blocked more often undergo apoptosis in response to TNF than normal cells 
because the survival pathway, including NFκB signaling is locked. It seems as if 
the availability of NFκB influences the ability of TNF to act as an apoptosis 
inducer and anti tumor agent. (Hong 2007) 
In the signal transduction of this pathway a lot of enzymes are involved again. 
Again they can activate each other through phosphorylation or build up protein 
complexes for a better signaling system.  
In the case of apoptosis-induction, the TNFα pathway includes the proteins p55-
TNFR (the TNF receptor), the Death Domain Proteins TRADD, FADD and RIP 
(these three proteins form the Death Inducing Signaling Complex [DISC]) and 
Caspase 8, which induces cell death. 
In the protective pathway, additional proteins are needed: IKK, IκB and NFκB the 
mechanism of these proteins, their interactions and their inhibition have already 
been described above. (Hong 2007) 
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Figure  6 TNFα Signaling (Hong 2007) 
 
 
NFκB signaling 
Nuclear Factor kappa B proteins are also called Rel proteins, they include 
p52/p100, p50/p105, c-Rel, RelA/p65 and RelB. These proteins can function as 
transcription factors when they are in their dimeric form. As transcription factors, 
they control gene expression of a broad range of genes, regulating 
inflammation, innate and adaptive immunity, stress responses, B-cell 
development and lymphoid organogenesis. Normally Rel proteins are inhibited 
by an IκB complex, which binds to the proteins and thereby stops their function. 
The IKK complex is activated by LPS, proinflammatory cytokines, growth factors 
or antigen receptors. This activated IKK complex is able to dissociate IκB from 
the Rel protein by phosphorylation. Phosphorylating IκB leads to ubiquitylation 
and degradation and furthermore free Rel proteins. Furthermore, the NFκB/Rel 
proteins can translocate to the nucleus and either alone or in combination with 
other transcription factor families start the transcription of its target genes. 
(Hayden and Ghosh 2008) 
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Figure  7 Signaling through NFkB (Alberts, Bray et al. 2005) 
 
The alternative pathway signals through activation of the NFkBp100/RelB 
complex. This complex is inactive under normal conditions but a set of 
receptors is able to activate it. Furthermore a kinase, called NIK, is activated 
cytosol 
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and in turn activates the IKKα complex which is responsible for phosphorylation 
of the NFkBp100 complex. This phosphorylation leads to an ubiquitination and 
further proteasomal processing to NFkBp52. The newly formed NFkBp52/RelB 
complex is transcriptionally active, is able to translocate into the nucleus and 
induce target gene expression. (Hayden and Ghosh 2008) 
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Figure  8 Alternative Pathway (Alberts, Bray et al. 2005) 
 
 
PPARγ signaling 
The Peroxisome Proliferator-Activated Receptor (PPAR) belongs to the 
superfamily of hormone receptors. It regulates transcription over a ligand 
dependent manner. The regulation of transcription is managed by binding to the 
Retinoid-X-Receptor (RXR). The product is a heterodimeric transcription factor 
cytosol 
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complex. This complex binds to the promoter regions of its target genes and 
promotes transcription. The heterodimeric transcription factor complex targets 
genes that are involved in the catabolism of fatty acids. When the heterodimeric 
complex of PPAR is bound to the RXR, it can either be active or inactive. For 
the inactivation, it must be bound to the Nuclear Receptor Corepressor (NCOR) 
or to the Silencing Mediator for Retinoid and Thyroid Hormone Receptor 
(SMRT). When a ligand appears, the corepressor dissociates and an activation 
of co-activators, such as Steroid Receptor Coactivator1 (SRC1), CREB-Binding 
Protein (CBP/p300), the Tuberous Sclerosis Gene-2 product, the PPAR binding 
protein, PPAR-Gamma Coactivator 1 and 2 (P-GammaC1/2) and Ara70. The 
activated form of the PPAR:RXR complex binds to the PPRE region in the 5´ 
region of the target genes and starts with the transcriptional regulation. When 
PPARs are activated, they bind to the DNA and regulate the transcription of 
their target genes. (Boitier, Gautier et al. 2003) 
The necessary ligands for PPAR are either synthetic, such as hypolipidaemic 
drugs, anti-inflammatory or insulin-sensitizing drugs. There are also known 
endogenous PPAR ligands, like fatty acids or their derivates. PPAR is included 
in a range of processes inside the cell, these processes can either be part of the 
normal regulatory system or disease-like. It is involved in lipid- and energy 
metabolism, inflammation, embryo implantation, diabetes and cancer. Different 
tissues show different balances of its isoforms (α,β/δ,γ). Every isoform shows a 
responsibility for the lipid metabolism, although every single isoform has been 
shown to have its own specific functions. (Park, Vogelstein et al. 2001) 
PPARα: It is highly expressed in tissues that show a high rate of mitochondrial 
fatty acid oxidation. Examples are liver, heart, muscle, kidney and cells of the 
arterial wall (for example smooth-muscle cells, endothelial cells and monocyte-
derived macrophages). Furthermore PPARα is activated by fibrates, fatty acids, 
eicosanoids, 15-Deoxy-Delta Prostaglandin-J2 (15-d Ptg) and oxidized fatty 
acids. (Martin 2009) 
PPARγ: It is especially expressed in adipose tissue but can be found in nearly 
every tissue because it is activated by fatty acids and their derivates. It plays an 
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important role in insulin sensitivity, adipogenesis and placental function. PPARγ 
has already been shown to have a function in transcription activation, neoplastic 
processes and colorectal cancer. Thiazolidinedione (TZD) is a class of 
antidiabetic drugs which act as PPARγ ligands. (Martin 2009) 
PPARβ: It is found in nearly every tissue and is only weakly activated by fatty 
acids, Ptgs and leukotrienes. This receptor has no known physiological ligand.  
The activity of PPARγ and PPARα can be regulated by phosphorylation of 
specific protein complexes. In the activation system, adaptor molecules, like 
SH2 containing protein (SHC) and the Growth Factor Receptor-Bound Protein-2 
–Son of Sevenless (GRB-2-SOS) are recruited by specific growth factor 
receptors. Furthermore, the Ras protein is phosphorylated, which in turn 
activates MAPKs of the Extracellular Signal Regulated Kinase (ERK) type. This 
type of kinase occurs when Tumor-Growth-Factor (TGF)-Beta Activated Kinase-
1 (TAK1) and MAPK/ERK (MEK) are activated. The activity of PPARα and 
PPARγ is inhibited by these kinases. On the other hand PPARα is activated by 
G-Protein Coupled Receptor (GPCR) induced phosphorylation of Protein-
Kinase-A (PKA) by cyclic Adenosine-3, 5' Monophosphate (cAMP) or p38 
MAPK. The differential regulation of the activation of PPAR gives the cell the 
possibility to control the target gene expression of PPAR in a very rapid manner 
and to give a fast response to extracellular signals. (Kelly 2001) 
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Figure  9 PPARγSignaling 
Internet: 
http://www.google.at/imgres?imgurl=http://208.52.138.117/iapp/maps/ppar.gif&imgrefurl=http://2
08.52.138.117/iapp/ppar.html&usg=__Q07pHLe_UKweuPlPhI2ivPUeEfA=&h=335&w=290&sz=
31&hl=de&start=57&zoom=1&um=1&itbs=1&tbnid=PTzCvtZnwZjpfM:&tbnh=119&tbnw=103&pr
ev=/images%3Fq%3Dpparg%2Bsignaling%26start%3D42%26um%3D1%26hl%3Dde%26sa%3
DN%26ndsp%3D21%26tbs%3Disch:1 ( accessed  22.September.2010) 
Mutations in the structure of PPARγ can change its functions and cause an 
insulin resistance syndrome, hypertension and dyslipidemia. PPARγ inhibits the 
inflammatory response of monocytes and macrophages by prevention of an 
activation of NFκB. When the cell is not stimulated, NFκB is bound to a 
corepressor complex, existing of NCoR, Histone Deacetylases 3 (HDAC3), 
TBL1 and TBLR1. In this state NFκB is actively repressed. Agents like LPS 
activate the NFκB pathway and the corepressor complex is degraded by an 
ubiquitination-dependent mechanism. Furthermore, instead of the corepressor 
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complex a coactivator complex binds to NFκB. This coactivator complex further 
initiates the transcription by activation of the transcription factor NFκB. When 
PPARγ ligands are present, they lead to a sumoylation of PPARγ, which is 
afterwards able to prevent the exchange of corepressor and coactivator 
complex and lead to a transrepression of the NFκB dependent promoters. This 
transrepression maintains the actively repressed state and prevents cytokine 
expression through the transcription factor NFκB. (Bailey and Ghosh 2005) 
 
Figure  10 Active Repression (Bailey and Ghosh 2005) 
 
 
 
Figure  11 Activated State (Bailey and Ghosh 2005) 
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Figure  12 Transrepression (Bailey and Ghosh 2005) 
 
Probiotics 
The World Health Organization (WHO) defines probiotics as “Probiotics are 
essentially helpful, live organisms, usually bacteria, that are used to change or 
re-establish the intestinal or gut flora and improve our health. They are usually 
given as part of our food, but can be introduced into our bodies in other ways.” 
Internet:http://www.paho.org/English/CFNI/NyamnewsNov1-205.pdf (accsessed 
28.9.2010) 
It has been shown several times that the microflora of the gut, containing a 
diverse population of nonpathogenic bacteria, has an influence on the health 
status and the innate immune system of all mammals. The complex cascades 
that are necessary for the signal transduction after pathogen microorganisms 
have attached to the cell surfaces have already been described. All these 
cascade-mechanisms are necessary for the development of an inflammatory 
process or even a disease. The estimated number of total microorganisms in 
the human gut, with around 1014, is even higher than the number of mammalian 
cells, with around 1013. Looking at the extreme range of bacteria in the gut and 
their important role for the development and shaping of the immune system, it is 
not surprising that the microorganisms communicate in some respect with each 
other and with the host. The way of communication, the interaction between 
probiotics and host and the cellular and molecular mechanisms of how bacteria 
Pol II – Polymerase II  
 SUMO – Small Ubiquitin Related 
Modifier 
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stimulate and influence the immune system, are not already clear. (Clarke and 
Sperandio 2005) 
Bacterial moieties can bind to receptors expressed on the apical or basolateral 
side of the surface of epithelial cells. The binding activates a signaling cascade 
inside the cell, of course depending on the receptor and the substance or 
bacterium that binds. This signaling cascade might trigger the expression of 
proinflammatory genes. In the human gut, cells are tolerant against their usual 
microflora, to prevent an ongoing inflammatory response. This tolerance 
mechanism can be attributed to CD4-protein and T-cell (in the lamina propria) 
activities. (Kelly, Campbell et al. 2003) 
 
• Lactobacillus acidophilus NCFM 
Lactobacilli are the largest genus of the lactic acid bacteria group. They 
predominantly appear in the gut, vaginal and oral regions of mammals. 
Lactobacilli also play an important role in cheese and yoghurt production. By 
creating lactic acid, they decrease the pH-value in food. Lactobacillus is a short 
gram-positive rod. Lactobacillus acidophilus NCFM was first isolated from 
human excrements. It is commercially available in the USA since the 1970s. 
This specific strain produces Lactacin B, a bacteriocin, which shows 
antimicrobial activity against other Lactobacilli and Enterococcus faecalis. If 
Lactobacillus acidophilus colonizes in the gut, it is able to influence the host´s 
microbial population in favor of his/her health. (Sanders and Klaenhammer 
2001) 
• Streptococcus thermophilus 
This species is a lactic acid bacterium too and commercially used in the milk-, 
cheese- and dairy products production. It is thermophilic, gram-positive and 
occurs as coccus in pairs or chains. It is able to produce ATP in the presence of 
oxygen by aerobic respiration and without oxygen through fermentation (a 
facultative anaerobe bacterium). Streptococcus thermophilus does not have the 
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ability to move or form spores. It is closely related to other pathogenic 
Streptococci but is not pathogenic itself. (Bolotin, Quinquis et al. 2004) 
 
• Bifidobacterium lactis 
Belongs to Bifidobacterium longum, which colonize the gastrointestinal tract  
(GIT) and the vagina. Bifidobacteria are gram-positive, anaerobe, branched, 
rod-shaped, not able to move and not able to form spores. Bifidobacteria 
ferment sugars into lactic acid and lower the pH-value in the intestine. 
Bifidobacterium longum is the most often recognized species in the human gut 
and was found to be the first inhabitant in new born infants, especially in breast 
fed infants. It has beneficial effects on the host´s health. Infants fed a formula 
diet seem to have a different microflora and are more at risk of diarrhea and 
allergies than breast fed infants. (Reinert 2002) 
 
LPS, used as a control 
Lipopolysaccharides are constructs of lipids and polysaccharides, building up 
large molecules. Gram-negative bacteria produce them on their outer cell 
membrane. LPS is necessary to protect the bacterium from outer influences, 
such as chemicals. LPS initiates strong immune responses in animals and 
human beings. The seriousness of its endotoxin abilities depends on the type of 
LPS. LPS binds to the CD14/TLR4/MD2 receptor complex, initiating the 
secretion of several cytokines through activation of a range of transcription 
factors in human cells. (Stewart, Schluter et al. 2005) 
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Objectives 
 
The growing number of people suffering from chronic inflammatory diseases is 
increasing dramatically. The positive influences of probiotics on inflammatory 
processes have already been discussed in different publications. (Zhang, Li et 
al. 2005) The aim of this work was to observe the influences of food 
components, Lactobacillus acidophilus NCFM, Streptococcus thermophilus 
ST21, Bifidobacterium lactis 420 and LPS in particular, on the expression of 
inflammatory genes. The mRNA expression of signaling mediators, such as IL6 
and TNFα was measured as well as the expression of the transcription factor 
NFκB. To investigate anti-inflammatory activities, the expression of PPARγ was 
tested too. These genes are important marker of inflammatory mechanisms in 
human cells. The cell system CACO2 was chosen because it serves as a model 
for mature enterocytes. The influence of probiotics and LPS on the expression 
of inflammatory genes was analyzed on both, inflammatory pre- and not-
prestimulated cells. The outcomes may contribute to the understanding of how 
probiotics and LPS can influence inflammatory processes in the human gut and 
if manipulation with designed probiotics could alter inflammatory processes. 
To further enhance this understanding, the expression of miRs after treatment 
with the already mentioned probiotics and LPS was analyzed. Again the 
CACO2 cell system was chosen as model for mature enterocytes. These 
outcomes may give some more information of how bacteria influence the gene 
expression in human cells.  
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Materials and Methods 
Polymerase Chain Reaction (PCR) and Real time PCR 
Both types follow the same principle of DNA amplification. Thus it is possible to 
detect even low amounts of DNA in a PCR. In the real time PCR the monitoring 
of the PCR products is done during the run (in real time), in the case of end 
point PCR this monitoring can soonest been done after the PCR run. All real 
time PCR analysis were done with the Applied Biosystems (ABI) StepOnePlus 
Instrument with 96 wells. 
Things needed for a PCR reaction: 
• Deoxynucleotidetriphosphats (dNTPs): dNTPs of the four DNA bases 
Adenine, Guanine, Cytosine and Thymine are needed for building up 
new DNA strands. 
• DNA-Polymerase: This enzyme is needed to build up the new DNA 
strands out of the dNTPs. 
• Magnesium-chloride: The DNA-Polymerase needs this substance as a 
cofactor. For a successful PCR Magnesium-chloride must be added.  
• Primers: These oligonucleotides are about 15-40 base pairs long and 
serve as starting point for the DNA-Polymerase. Primers are necessary 
because the DNA-polymerase is not able to do the replication on its own, 
needs starting oligonucleotides which can be elongated during the PCR 
reaction. It is also necessary to add a forward and a reverse primer to 
amplify the double stranded DNA. The oligonucleotides furthermore bind 
to their complementary sequence on the DNA strand.  
• Fluorescent reporter: This reporter has the ability to bind to the DNA and 
gives the possibility to detect and quantify it. This is only possible in real 
time PCR, not in the end-point system. 
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Different steps in the PCR reaction setup: 
The setup consists of 30-40 cycles of denaturation, annealing and 
elongation 
1. The first step is the denaturation step, at 90-99°C, this step is needed to 
denature the DNA. 
2. In the annealing-step, the primers bind to their complementary sequence 
on the target DNA. The temperature of this step depends on the primer-
structure and varies for every primer. Usually it is between 50°C and 
70°C. 
3. The Elongation step is necessary for the polymerase to build up the 
desired DNA strand, starting at the annealed primer. The temperature of 
this step is usually 72°C. 
              Figure  13 Principle of a PCR reaction (Torak et al.) 
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There are three principle methods for real time PCR detection: 
1. Hydrolysis probe technique 
2. Hybridization probe technique 
3. DNA-binding agents 
Ad 1.: 
In addition to the two primers, a third oligonucleotide is added, a so called 
probe. This probe must fit to the sequence between the forward and the reverse 
primer. At the 3´and the 5´end of the probe there is a fluorescent dye 
(fluorochrome), this dye is also called reporter, and a quencher bound. As long 
as the probe is intact, the quencher absorbs the fluorescence signal of the 
reporter. But during elongation the probe is destroyed. Thus the fluorescent dye 
and the quencher are separated and the signal can be detected. 
Ad 2.: 
For this system two oligonucleotides, which bind directly next to each other on 
the Sequence, are needed as reporters. One of these oligonucleotides is 
labeled with a donor fluorochrome, the other one with an acceptor 
fluorochrome. When both fluorochromes anneal to the DNA, the emitted light of 
the donor excites the acceptor, whose emitted fluorescence can be detected 
during annealing. The signal increases after every PCR cycle, because there 
are more DNA copies after every cycle, which the probes can anneal to. 
Ad 3.: 
A fluorescent agent binds to the double stranded DNA sequence after the 
elongation step. In this way the signal increases with every PCR cycle, because 
after every cycle more DNA is available to bind to. One of the most popular 
dyes for this type of real time PCR is Sybr Green, which was also used for the 
experiments in this work. 
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Cell Culture 
In this experiment, CACO2 cells were used. CACO2 cells are immortalized cells 
of a human colon carcinoma. These cells act as a model for the colon epithel. 
The cells were grown in a medium containing in 50ml Fetal Bovine Serum 
(FBS), 5ml P/S/G, 1 ml Ne-Pyr in 450ml medium. They were passaged every 3-
4 days with acutase because trypsine was mentioned to be cell toxic.  
For the following experiments, CACO2 cells were grown onto 24 well plates for 
the gene expression analysis and on 6-well plates for the miR analysis because 
for the miR analysis more cell material was necessary. In the 6 well plates, 
3x106 cells were seed, in the 24 well plates 2x105. They were kept in an 
incubator at 37°C and 5% CO2. The experiments for gene expression were on 
the one hand done with prestimulation of IL1β, on the other hand without 
prestimulation. The prestimulation was necessary to initiate an inflammatory 
status before the substances (probiotics and LPS) were added to see the effect 
on the inflammatory gene expression. In the case of prestimulation, cells were 
incubated with IL1β for 24 hours before the treatment with food components 
started. The added concentration of IL1β was 10ng/ml. Used food components 
were probiotics and LPS in the following concentrations: 
 
Substance Concentration 
LPS 10μg/ml 
Lactobacillus acidophilus NCFM 5x108 CFU/ml  
Streptococcus thermophilus ST21 5x108 CFU/ml 
Bifidobacterium lactis Bt420 1x109 CFU/ml 
 
Table 1 List of Substances and their used Concentrations 
 
All concentrations were chosen because of experiences of the lab or because of 
well established literature. The probiotics were achieved from Danisco 
(Madison, USA) in lyophilysed state. They were solved in ddH2O and heat 
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inactivated by warming them for 30 minutes on the heat block at 96°C. 
Afterwards they were immediately cooled down to 4°C.  
The cells were harvested, after incubation with the above described 
substances, after 3, 24 and 48 hours.  
The harvesting procedure included: 
1. Remove liquid media 
2. Wash twice with ice-cold PBS from genXpress (Wiener Neudorf, Austria) 
3. Harvesting cells with a policeman cell scraper and stored in PBS for 
further DNA analysis, in RLT buffer from Qiagen (Hilden, Germany) (first 
buffer of the RNA isolation kit) for further RNA analysis or in trizol from 
Invitrogen (Paisley, Scotland) for miR analysis. 
4. Freezing cells down on -20°C before further processing 
 
Gene Expression 
In a gene expression assay, the content of mRNA of a specific gene is 
quantified. The mRNA is the product of DNA transcription and the content of 
mRNA is directly proportional to the gene activity. For the detection of mRNA, 
total RNA must be extracted from the cells and afterwards it is converted into 
cDNA. This is necessary for the stability of the sample because RNA tends to 
degrade very fast by RNAses, which ubiquitous. The convertion into cDNA is 
called reverse transcription.  
For the extraction of RNA the RNeasy Mini Kit from Qiagen (Hilden, Germany) 
was used, the extraction was done by the instruction applied. 
The reverse transcription was done with the Phusion RT-PCR Kit from 
Finnzymes (Epoo, Finnland). With the kit, three different primer are delivered for 
the reverse transcription of mRNA: 
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• Random-hexamer-primers: This is a mixture of oligonucleotides 
consisting of six randomly chosen base pairs, enabling the primers to 
bind to nearly every mRNA. 
• Oligo(dT) primer: These primers consist of only Thymine and bind to the 
polyA-tail of the mRNA. 
• Sequence specific primers: With this type of primers only single genes or 
parts of the target genes are converted into cDNA. 
In this work the Oligo(dT) primer was chosen for the reverse transcription. 8 μl 
of mRNA template were taken as template for starting. All other steps and the 
PCR conditions were done following the instruction applied.  
For the real time PCRs, the following reaction set up was chosen:   
Per aliquot 10μl of total reaction volume was prepared, this volume consisted of: 
• 5 μl MasterMix: SensiMix SYBR Kit from genXpress (Wiener Neudorf, 
Austria) was used 
• 1 μl Primer: the correct concentration was prepared before adding the 
primer, from Biomers 
• 3 μl nuclease free water 
• 1 μl cDNA 
The Magnesiumchloride (MgCl2) concentration for all assays was 3mM. The 
SensiMix already contains the Sybr Green dye for the real-time analysis. 
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The temperature conditions were as follows: 
Step Annealing Temperature Time 
Hot Start for the Activation 
of the Polymerase 
95°C 10 minutes 
Denaturation 95°C 30 seconds 
Annealing 57°C-60°C 40 seconds 
Elongation 72°C 30 seconds 
 Melt Curve  
 
Table 2 Temperature conditions of Real Time PCR 
 
 
Used primer pairs: 
Primer Sequence5´-3´ Annealing 
temperature 
Concentratio
n 
IL6 Forward:GGTACATCCTCGACGGCATCT 
Reverse:GTGCCTCTTTGCTGCTTTCAC 
59°C 10pmol/μl 
TNFα Forward:AAGAGGGAGAGAAGCAACTACAGA 
Reverse:GGTGGAGCCGTGGGTCAG 
60°C 2,5pmol/μl 
NFkBp65 Forward:AGAAAGAGGACATTGAGGTG 
Reverse:CCCCCAGGTCTTCATCATCA 
59°C 5pmol/μl 
PPARγ Forward:AAGTTCAATGCACTGGAATTAGATGA 
Reverse:TGTAGCAGGTTGTCTTGAATGTCTTC 
57°C 10pmol/μl 
GAPDH  Forward:CGACCACTTTGTCAAGCTCA 
Reverse:AGGGGAGATTCAGTGTGGTG 
51°C 5pmol/μl 
 
Table 3 Used Primers 
 
  
40  
cycles 
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Typically real time PCR curves look like this: 
 
Figure  14 Real Time PCR Curve 
This real time PCR run shows the expression of IL6 in CACO2 cells 
prestimulated with IL1β. The shown results were detected from cells treated 
with Bifidobacterium lactis and cells without treatment after prestimulation. 
 
miR Expression 
The used extraction kit for miRs was mirVana miR Isolation Kit from Life 
Technologies (Carlsbad, California). Just like mRNA, extracted miR is not very 
stable, so it was immediately transcribed into cDNA. The used reverse 
transcription kit was the QuantiMir RT Kit – Small RNA Quantitation System 
from System Biosciences (ordered at BioCat – Heidelberg, Germany). 
Everything was done according to the manual applied. The primers for the 
detection of miR 7i, 27b and 155 were also from System Biosciences (ordered 
at BioCat – Heidelberg, Germany). Typically the primers for miR detection 
consist of the full sequence of the miR. In this kit a universal reverse primer for 
all miRs was included. The miR were quantified using real time PCR. The 
SensiMix SYBR Kit from genXpress (Wiener Neudorf, Austria) was used. (The 
MgCl2 concentration of the SensiMix fit with the needed concentration of the 
polymerase for the reaction.)  
 
CACO2 cells 
prestimulated with IL1β 
CACO2 cells prestimulated with 
IL1β and treated with 
Bifidobacterium lactis for 24 hours 
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The temperature conditions were as follows: 
Step Temperature Time 
 50°C 2 minutes 
hot start for the activation 
of the polymerase 
95°C 10 minutes 
denaturation 95°C 15 seconds 
annealing 60-64°C 1 minute 
 Melt curve  
 
Table 4 Real Time PCR Conditions for miRNAs 
 
Specific primers needed their specific conditions: 
Primer Annealing Temperature Concentration 
miR7i 62°C 10μM 
miR27b 62°C 10μM 
miR155 62°C 10μM 
miR16 (human/mouse) 60°C 10μM 
U6 (human snRNA) 64°C 10μM 
 
Table 5 Detected miRNAs 
The principle of the QuantiMir kit for reverse transcription of miRs is the 
following: 
• The extracted miR becomes polyA tailed 
• An oligo-dT adaptor anneals to the prepared polyA tail and furthermore 
• Convertion to cDNA can start using  
• Reverse transcriptase to create “first strand cDNAs” 
This workflow ensures the convertion of all miRs in the sample to cDNAs. 
 
  
Control 
RNAs 
40  
cycles 
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Statistical Analysis 
 
The real time data were analyzed with the StepOne software belonging to the 
StepOne real time PCR Life Technologies (Carlsbad, California). Statistical 
analysis were performed using OriginPro 8G from OriginLab (Northampton, 
USA) for calculation of two tailed test for variances and a two tailed (student´s) 
t-test. Gene expression data were normalized to the expression of the 
housekeeping gene Glycerinaldehyde-3-phosphate Dehydrogenase (GAPDH) 
which is necessary for glycolysis. There is evidence that it is expressed 
constantly to all conditions in human cells. This fact gives the possibility to 
calculate a change in specific gene expressions, when the GAPDH expression 
stays the same. In the case of miR detection, the housekeeping RNA was U6, 
which is a snRNA, a small RNA. The principle for expression of this small RNA 
is the same for human cells like it is for GAPDH.  
The figures and Box-Plots have also been made by OriginPro 8G. Results were 
considered significant at p<0.05.  
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Results 
Gene Expression in IL1β Prestimulated Cells 
The results of prestimulation with IL1β for 24 hours, followed by a treatment with 
Lactobacillus acidophilus NCFM, Streptococcus thermophilus ST21, 
Bifidobacterium lactis Bt420 or LPS are declared for every figure in the following 
chapter. 
Control means the ratio of gene expression in prestimulated cells compared to 
gene expression of not prestimulated cells. 
(*shows significant alterations) 
 
IL6 Expression after 3 hours 
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Figure  15 IL6 Expression prestimulated 3 hours 
The expression of IL6 after Streptococcus, Bifidobacterium and Lactobacillus treatment 
was statistically significant higher than the expression of the control. 
Control Strepto
coccus* 
Bifido 
bacterium* 
Lactoba
cillus*  
LPS 
2^-ddCT 
3 hours 
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Streptococcus treatment depicted a 1.7-fold increase ± 0.5 SD, Bifidobacterium 
treatment a decrease to the 0.8-fold ± 0.2 SD, Lactobacillus a 1.4-fold increase 
± 0.4SD and LPS a decrease to the 0.6-fold ± 0.2SD in IL6 expression. 
 
IL6 Expression after 24 hours 
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Figure  16 IL6 Expression prestimulated 24 hours 
The expression after Streptococcus and Lactobacillus treatment was significantly higher 
than the control´s. 
 
The expression level of IL6 after 24 hours showed an increase to the 1.5-fold ± 
0.6 SD after Streptococcus treatment, a decrease to 0.4-fold ± 0.2 SD after 
Bifidobacterium treatment, a decrease to the 0.9-fold ± 0.5 SD after 
Lactobacillus treatment and a decrease to the 0.3-fold ± 0.3 SD after LPS 
treatment. 
24 hours 
Control Strepto
coccus* 
Bifido 
bacterium 
Lacto 
bacillus* 
LPS 
2^-ddCT 
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TNFα Expression after 3 hours 
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Figure  17 TNFα Expression prestimulated 3 hours 
The Expression of TNFα after LPS treatment was significantly decreased, compared to 
the control. 
 
After Streptococcus treatment the expression of TNFα was increased to the 1.6-
fold ± 0.6 SD, to the 1.05-fold ± 0.3 SD after Bifidobacterium treatment, equal 
after Lactobacillus treatment 1 ± 0.1 SD and decreased after LPS treatment to 
the 0.5-fold ± 0.3 SD.  
  
3 hours 
Control Strepto
coccus 
Bifido 
bacterium 
Lacto 
bacillus  
LPS* 
2^-ddCT 
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TNFα Expression after 24 hours 
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Figure  18 TNFα Expression prestimulated 24 hours 
The Expression level after Lactobacillus treatment differed significantly from the control. 
 
Treatment with Streptococcus showed a decrease in the expression of TNFα to 
the 0.7- fold ± 0.6 SD, a decrease to the 0.6-fold ± 0.2 SD after Bifidobacterium 
treatment, a decrease to the 0.7-fold ± 0.4 SD after Lactobacillus treatment and 
a decrease to the 0.5-fold ± 0.4 SD after LPS treatment. 
24 hours 
Control Strepto
coccus 
Bifido 
bacterium 
Lacto 
bacillus*  
LPS 
2^-ddCT 
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NFκBp65 Expression after 3 hours 
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Figure  19 NFkBp65 Expression prestimulated 3 hours 
Expression after Streptococcus treatment differed significantly from the control-
expression. 
 
The decreases in the expression of NFκB were as follows: after Streptococcus 
treatment 0.3-fold ± 0.2 SD, 0.5-fold ± 0.3 SD after Bifidobacterium treatment, 
0.4-fold ± 0.2 SD after Lactobacillus treatment and 0.4-fold ± 0.3 SD after LPS 
treatment. 
3 hours 
Control Strepto
coccus* 
Bifido 
bacterium 
Lacto 
bacillus  
LPS 
2^-ddCT 
Results |61 
 
NFκBp65 Expression after 24 hours 
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Figure  20 NFkBp65 Expression prestimulated 24 hours  
No significant alterations were found. 
 
The changes in the expression level after 24 hours showed a decrease to the 
0.4-fold ± 0.3 after Streptococcus treatment, a decrease to the 0.5-fold ± 0.5 SD 
after Bifidobacterium treatment, a decrease to the 0.4-fold ± 0.4 SD after 
Lactobacillus treatment and a decrease to the 0.2-fold ± 0.2 SD after LPS 
treatment. 
  
24 hours 
Control Strepto
coccus 
Bifido 
bacterium 
Lacto 
bacillus  
LPS 
2^-ddCT 
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PPARγ Expression after 3 hours 
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Figure  21 PPARγ Expression prestimulated 3 hours 
Bifidobacterium treatment increased the expression significantly compared to the 
control after 3 hours. 
 
Treatment with Streptococcus increased the expression of PPARγ to the 1.4-
fold ± 0.5 SD, treatment with Bifidobacterium increased the expression to the 
1.6 ± 0.3 SD, Lactobacillus treatment increased the expression to the 1.1-fold ± 
0.4 SD and treatment with LPS decreased the expression to the 0.8-fold ± 0.3 
SD. 
3 hours 
Control Strepto
coccus 
Bifido 
bacterium* 
Lacto 
bacillus  
LPS 
2^-ddCT 
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PPARγ Expression after 24 hours 
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Figure  22 PPARγ Expression prestimulated 24 hours 
The Expression level after Lactobacillus treatment was significantly increased compared 
to the control-expression. 
 
The expression after Streptococcus treatment showed a decrease in the 
expression level of PPARγ to the 0.6-fold ± 0.4 SD, Bifidobacterium treatment 
showed an equal expression level 1 ± 0.5 SD, Lactobacillus treatment showed 
an increase to the 1.3-fold ± 0.3 SD and LPS treatment showed a 0.4-fold ± 0.3 
SD decrease.   
 
  
24 hours 
Control Strepto
coccus 
Bifido 
bacterium 
Lacto 
bacillus*  
LPS 
2^-ddCT 
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Gene Expression without Prestimulation 
The same experiments, except Bifidobacterium lactis, have been done with 
CACO2 cells without prestimulation with IL1β. The results were the following 
(The control is at 1): 
 
IL6 Expression after 3 hours 
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Figure  23 IL6 Expression 3 hours 
The expression after LPS treatment was significantly higher than the expression of the 
control. 
 
Streptococcus treatment decreased the expression to the 0.7-fold ± 0.3 SD, 
Lactobacillus treatment increased the expression to the 1.6-fold ± 0.6 SD and 
LPS increased the expression to the 1.8-fold ± 0.7 SD. 
3 hours 
Strepto
coccus* 
Lacto 
bacillus  
LPS* 
2^-ddCT 
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IL6 Expression after 24 hours 
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Figure  24 IL6 Expression 24 hours 
Alterations after Streptococcus and LPS treatment were statistically significant. 
 
Streptococcus treatment decreased the expression to the 0.4-fold ± 0.3 SD, 
Lactobacillus treatment decreased the expression to the 0.8-fold ± 0.4 SD and 
LPS treatment decreased the expression to the 0.7-fold ± 0.2 SD. 
24 hours 
Strepto
coccus* 
Lacto 
bacillus  
LPS* 
2^-ddCT 
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TNFα Expression after 3 hours 
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Figure  25 TNFα Expression 3 hours 
No significant alterations. 
 
Streptococcus treatment changed the expression to the 1.1-fold ± 0.2 SD, 
Lactobacillus treatment changed the expression to the 1.3-fold ± 0.7 SD and 
LPS treatment changed the expression to the 1.5-fold ± 0.6 SD. 
 
3 hours 
Strepto
coccus 
Lacto 
bacillus  
LPS 
2^-ddCT 
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TNFα Expression after 24 hours 
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Figure  26 TNFα Expression 24 hours 
Streptococcus and LPS treatment changed the expression significant. 
 
After treatment with Streptococcus the expression was decreased to the 0.5-
fold ± 0.2 SD, treatment with Lactobacillus decreased the expression to the 0.8-
fold ± 0.4 SD and LPS treatment decreased the expression to the 1.7-fold ± 0.6 
SD. 
24 hours 
Strepto
coccus* 
Lacto 
bacillus  
LPS* 
2^-ddCT 
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NFκBp65 Expression after 3 hours 
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Figure  27 NFkBp65 Expression 3 hours 
LPS treatment altered the expression significantly. 
 
The expression of NFκBp65 was decreased by Streptococcus treatment to the 
0.8-fold ± 0.4 SD, after Lactobacillus treatment it was equal 1 ± 0.3 SD and LPS 
treatment decreased the expression to the 0.3-fold ± 0.07 SD. 
3 hours 
Strepto
coccus 
Lacto 
bacillus  
LPS* 
2^-ddCT 
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NFκBp65 Expression after 24 hours 
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Figure  28 NFkBp65 Expression 24 hours 
Streptococcus and LPS changed the expression significantly. 
 
Streptococcus treatment showed a decrease in the expression to the 0.4-fold ± 
0.4 SD, Lactobacillus showed a decrease to the 0.8-fold ± 0.4 SD and LPS 
showed a decrease to the 0.3-fold ± 0.3 SD. 
24 hours 
Strepto
coccus* 
Lacto 
bacillus  
LPS* 
2^-ddCT 
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PPARγ Expression after 3 hours 
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Figure  29 PPARγ Expression 3 hours 
The expression level after LPS treatment was significantly different than the expression 
level of the control. 
 
Streptococcus treatment did not alter the expression 1 ± 0.1 SD, Lactobacillus 
treatment also did not show a changed expression level 1 ± 0.2 SD and LPS 
changed the expression to the 1.8-fold ± 0.7 SD. 
3 hours 
Strepto
coccus 
Lacto 
bacillus  
LPS* 
2^-ddCT 
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PPARγ Expression after 24 hours 
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Figure  30 PPARγ Expression 24 hours 
No significant alterations. 
 
Streptococcus treatment increased the expression to the 1.1-fold ± 0.4 SD, 
Lactobacillus treatment did not alter the expression 1 ± 0.3 SD and LPS 
increased the expression to the 1.2-fold ± 0.2 SD.  
 
 
 
  
24 hours 
Strepto
coccus 
Lacto 
bacillus  
LPS 
2^-ddCT 
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miR Level after Probiotic Treatment 
Cells for miR detection have not been prestimulated with IL1β. The control was 
set to 1. After treatment with Lactobacillus acidophilus, Streptococcus 
thermophilus or LPS for 24 hours, the miR levels were as follows:  
 
Lactobacillus acidophilus: 
miRNA 7i miRNA 27b miRNA 155
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Figure  31 miR Expression after Lactobacillus treatment 
The levels of all three miRs differed significantly from the control. All tested miRs were 
significantly decreased after 24 hours. 
 
The treatment with Lactobacillus decreased the expression of miR7i to the 0.9-
fold ± 0.2 SD, the miR27b expression was decreased to the 0.9-fold ± 0.09 SD 
and the miR155 expression was increased to 1.3-fold ± 0.9 SD. 
  
* * * 
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Streptococcus thermophilus: 
miRNA 7i miRNA 27b miRNA 155
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Figure  32 miR Expression after Streptococcus treatment 
The expression of miR7i was significantly lower after Streptococcus treatment than in 
the control. 
 
After Streptococcus treatment, miR7i expression was decreased to the 0.9-fold 
± 0.1 SD, miR27b expression was decreased to the 0.7-fold ± 0.3 and the 
miR155 expression was equal 1 ± 0.9.  
 
  
* 
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LPS: 
miRNA 7i miRNA 27b miRNA 155
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Figure  33 miR treatment after LPS treatment 
The treatment with LPS resulted in a decrease in all miRs. Only miR7i was statistically 
significant decreased.  
 
The LPS treatment changed the miR expression as follows: miR7i was 
decreased to the 0.3-fold ± 0.1 SD, miR27b was decreased to the 0.4-fold ± 0.2 
SD and miR155 was decreased to the 0.3-fold ± 0.1 SD 
  
* 
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Abstract 
Non invasive therapies for chronic inflammatory diseases are becoming of 
greater interest. Since several publications reported a positive influence of 
probiotics on inflammatory processes investigations in this direction are forced 
forward. The complex and specific signaling cascades, stimulated by probiotics 
show that the kind of bacteria has a high impact on the anti-inflammatory 
potential. 
The aim of this study was to investigate if the expression of inflammatory 
mediators, Interleukin 6 (IL6) and Tumor Necrosis Factor α (TNFα) in particular, 
inflammatory transcription factors, NFκB, and anti-inflammatory genes, such as 
PPARγ, are altered after the exposure to probiotics and LPS. (LPS was used as 
a control) To investigate the direct influences on the gene expression, probiotic 
treatment was done directly onto the cells. Influences on already existing 
inflammatory processes have been observed by a prestimulation of cells with 
Interleukin 1β (IL1β), 24 hours before probiotical treatment. The expression of 
micro RNAs (miRs) which are presumably involved in the expression of the 
discussed genes was watched too, in particular miR7i, miR27b and mir155. The 
Colon Carcinoma cell system CACO2 was chosen for this study. 
For the detection of gene expressions, as well as miR expression, quantitative 
real time PCR was used. Lactobacillus acidophilus NCFM, Bifidobacterium 
lactis 420 and Streptococcus themrophilus ST21, first lyophilized, were 
dissolved in water and heat inactivated. LPS was from E. coli.  
The results showed a trend for probiotics to enhance the expression of 
inflammatory mediators, IL6 and TNFα in particular, but no increase in the 
expression of the transcription factor NFκB. Different probiotics showed different 
effects on the expression levels, contributing to the suggestion that they initiate 
different signaling pathways in the host´s enterocytes. Especially Streptococcus 
treatment often showed dramatically different effects on the gene expression 
than other probiotics. LPS showed expected different results than the probiotcs 
but not expected decreases in the expression level of most genes after 
Results |76 
 
prestimulation with IL1β. PPARγ expression was slightly increased after most 
treatments. 
miR expression levels also changed dramatically after treatment with 
Lactobacillus, Streptococcus and LPS. A decrease in the miRs 7i and 27b could 
be observed after every probiotical treatment. Contrary miR 155 expression 
increased after Lactobacillus and Streptococcus treatment but not after LPS 
treatment. 
Taken together the results of this study confirm with findings of other studies, 
claiming that probiotics can influence the inflammatory status. Further analysis 
must be done for a clear understanding of the initiated signaling pathways and 
gene expressions. 
 
Draft – publication in progress.  
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Discussion 
 
To investigate the influences of probiotics on inflammatory processes, in vitro 
studies are a popular method. They show clear results and can be easily 
controlled. Effects in vivo can be contemplated but no conclusions can be made 
for sure. 
 
CACO2 cell model 
All experiments were done with CACO2 cells which were harvested at 80-90% 
confluency. This experimental design allows a comparison with previous studies 
because the CACO2 cell model is a popular one. Of course CACO2 cells serve 
just as a model which makes it difficult to transfer the results to an in vivo 
system. 
 
IL6 Expression 
In IL1β prestimulated CACO2 cells the expression of IL6 was significantly 
higher after treatment with Lactobacillus acidophilus, Streptococcus 
thermophilus and Bifidobacterium lactis, compared to untreated cells. The 
control was calculated as the difference in the expression of IL6 between 
prestimulated CACO2 cells without treatment and not prestimulated CACO2 
cells without treatment. This experimental design made it possible to see the 
differences of the specific treatment. Contrary in the not prestimulated CACO2 
cells the treatment with Lactobacillus did not alter the expression of IL6 
significantly. Only the treatment with LPS after 3 and 24 hours and 
Streptococcus after 24 hours showed significantly increased IL6 mRNA levels.  
These findings have already been reported by Reilly et al. in 2007. They also 
treated prestimulated and not prestimulated CACO2 cells with Lactobacillus 
paracasei and Lactobacillus plantarum, to investigate the protective effect of 
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these probiotics. This group could not see an effect of the probiotics without 
prestimulation too but the treatment after prestimulation also showed an 
extreme increase in IL6 expression. They used living and heat inactivated 
Lactobacilli and found similar results. The group also showed that the effect was 
not initiated by any product secreted from the probiotics. In their publication, 
Reilly et al. stated that the effect of the heat inactivated probiotics may be 
caused by the heat shock proteins. When they knocked out hsp70 and hsp27, 
which are expressed at higher levels after heat inactivation, the potentiating 
effect of living probiotics on IL6 expression was gone. Furthermore, they 
claimed that the potentiating effect of IL6 expression has an anti-inflammatory 
background. Because it was shown that IL6 has anti-inflammatory effects on the 
intestinal mucosa. (Reilly, Poylin et al. 2007) 
The IL6 expression without prestimulation was increased after 3 hours and 
decreased after 24 hours. Mietinnen et al. already showed in 1996 that the 
treatment of Peripheral Blood Mononuclear cells (PBMC) with different lactic 
acid bacteria or LPS leads to an increased amount of TNFα and IL6, detected 
by Enzyme Linked Immuno Sorbent Assay (ELISA). These results suggest that 
the mRNA level is lowered after 24 hours because the translation of most of the 
mRNA into proteins has already taken place. (Miettinen, Vuopio-Varkila et al. 
1996) 
The expression of IL6 mRNA seems to take longer than the expression of TNFα 
mRNA. Thus in this work the peak of the expression level of IL6 might be not 
visible because it may be between 3 hours and 24 hours of treatment. Agarwal 
et al. showed that the increases in the expression of TNFα, IL1β and IL8 appear 
soon after treatment with LPS but the IL6 expression increase takes longer. It 
seems that this cytokine differs from the others and this would contribute to the 
thesis that IL6 acts as an anti-inflammatory cytokine. (Agarwal, Piesco et al. 
1995) 
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TNFα Expression 
In this work, the mRNA level was analyzed after 3 and 24 hours. In the case of 
TNFα, the mRNA level was increased after 3 hours and decreased after 24 
hours.  
Mietinnen et al. showed that after 24 hours treatment with different lactic acid 
bacteria, the protein level of TNFα increased dramatically. Like in the case of 
IL6, this could be the effect of an increased translation process. The authors 
concluded their findings in a stimulation of a nonspecific immune response by 
lactic acid bacteria. (Miettinen, Vuopio-Varkila et al. 1996) 
Agarwal et al. studied the effect of different types of LPS onto the gene 
expression of different cytokines in monocytes. What they found was that E.coli 
LPS, which was used in this work too, increased the amount of TNFα and IL6 
mRNA the least compared to LPS from other microbes. The time course of the 
expression levels showed that TNFα mRNA was rapidly expressed after LPS 
treatment and decreased fast after 3 hours.  
It might be that the peak of TNFα expression could not be depicted in this study 
because it has already past after 3 hours. (Agarwal, Piesco et al. 1995) 
 
NFκBp65 Expression 
Rousseaux et al showed in 2007 that Lactobacillus acidophilus NCFM is able to 
induce, over direct contact with epithelial cells, an NFκB directed expression of 
opioid and cannabinoid receptors. These results suggest a direct influence of 
Lactobacillus acidophilus NCFM onto the NFκB signaling cascades. 
(Rousseaux, Thuru et al. 2007) 
Su et al. claimed 1999 that they found a time kinetic in NFκB expression. They 
stimulated CACO2 cells with IL1β and recognized a rapid increase in IL8 
mRNA. An immunoblot of IκB (inhibitory protein of NFκB which prevents the 
transcription factor to translocate into the nucleus and initiate the transcription of 
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inflammatory genes) showed that the protein was rapidly decreased within 10 
minutes after stimulation with IL1β. After 80 minutes a reappearance of IκB 
could be recognized. After 180 minutes there was still less IκB but more NFκB 
followed by an increased expression of TNFα and IL6. After 24 hours, IκB was 
back at the level it was before the treatment, followed by a decreased TNFα 
level. (Su, Wen et al. 1999) 
In this work, the expression of NFkB in prestimulated CACO2 cells was highest 
in the control after 3 hours, according to Su´s findings that IκB is decreased 
after 180 minutes. The treatment with probiotics and LPS seemed to decrease 
the inflammatory cascade because the expression of NFκBp65 was less than in 
the control with only Streptococcus thermophilus being statistically significant. 
After 24 hours, the NFκB expression was decreased by all treatments, 
consistent with the claim that after 24 hours the protein level of IκB is high 
enough again to inhibit the NFκB function. Also consistent with the fact that 
within all treatments the IL6 and the TNFα expression was lower after 24 hours 
than after 3 hours in prestimulated cells. 
 
PPARγ Expression 
Bailey et al. claimed that PPAR ligands are able to inhibit the expression of 
genes which are responsible for inflammatory activities in the cell. As already 
discussed, PPAR ligands play a very important role in inhibiting the transcription 
factor NFκB. (Bailey and Ghosh 2005) 
In this work, the expression of NFκB in not prestimulated CACO2 cells was 
lowest after 3 hours treatment with LPS, consistent with Su´s findings but also 
consistent with the PPARγ expression, which was highest after 3 hours after 
LPS treatment. 
In prestimulated CACO2 cells, the expression of PPARγ was significantly 
increased after 3 hours treatment with Bifidobacterium and after 24 hours 
treatment with Lactobacillus.  
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Even though a real trend for an anti-inflammatory effect of PPARγ after all 
treatments could not be reported in CACO2 cells, maybe due to the fact that 
PPARγ appears and functions more often in adipocytes, skeletal muscle cells, 
osteoclasts, osteoblasts and several immunetype cells.(Martin 2009) 
 
miR 7i 
Chen et al. showed that Clostridium parvum decreases, over a MyD88/NFkB 
dependent pathway, the expression of miR7i and in this way increases the 
expression of TLR4. (Chen, Splinter et al. 2007) 
The findings of this work show that miR 7i was statistically significant decreased 
by all treatments, whereas the treatment with LPS showed the lowest levels of 
miR7i. Consistently, also NFκB expression was lowest after LPS treatment. This 
may be due to an increased expression of TLR4, which is responsible for the 
LPS response in the cell. 
 
miR 27b 
Jennewein et al. showed a decrease in PPARγ expression after LPS treatment, 
due to the repression through miR27b, which seems to regulate the PPARγ 
mRNA translation, in monocytes. (Jennewein, Knethen et al. 2010) 
In this work, the expression of PPARγ increased after LPS treatment, but the 
miR27b level decreased. It is of course possible that these opposite results can 
be attributed to the different cell model. Another possible reason is that 
harvesting was too late for Jennewein´s findings (24 hours) and the expression 
levels already reversed again. As already mentioned, PPARγ does not have its 
target tissue in CACO2 cells. 
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miR 155 
O´Connell et al. found an upregulation of miR155 after LPS stimulation in 
hematopoietic stem cells after LPS treatment. (Connell, Rao et al. 2008) 
Furthermore, they found that miR155 was the only one out of 200 miRNAs they 
tested that was induced by all agents added, as there were different TLR 
lignads, as well as by LPS. Experiments were done in human monocytes. 
O´Connell et al. claim that the miR 155 pathway uses MyD88 and TNFα for 
signaling. The signaling cascade induced by TNFα is fast leading to a fast 
miR155 expression. (O’Connell, Taganov et al. 2006) 
In this work, an increase of miR155 expression after LPS treatment could not be 
found. This may be either contributed to the different cell system or to the 
duration of the treatment, because O´Connell et al. measured the expression 
after 6 hours so that the peak of the expression level maybe was already gone. 
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Summary 
 
In this work the changed expression of Interleukin 6 (IL6), Tumor Necrosis 
Factor α (TNFα), Nuclear Factor kappa B, subunit p65 (NFkBp65) and 
Peroxisome Proliferative activated Receptor γ (PPARγ) was analyzed after 
treatment with the probiotics Lactobacillus acidophilus NCFM, Bifidobacterium 
lactis 420, Streptococcus thermophilus ST21 and Lipopolysaccharides (LPS). 
All of these components were added to either not prestimulated cells or to 
Interleukin 1β (IL1β) prestimulated cells. This ensured that on the one hand the 
effect of the probiotics and LPS on the cell system and on the other hand their 
effect on inflammatory processes, induced by IL1β, in this specific cell system 
could be observed. The expression level of the micro RNAs miR7i, miR27b and 
miR155 was also measured after treatment with LPS, Lactobacillus acidophilus 
and Streptococcus thermophilus. The used cell system was the Colon-
Carcinoma cell line CACO2. 
Epigenetics is characterized by a change in gene expression without a change 
in the DNA sequence. Different food components are able to modify the 
expression level of specific genes. The signaling pathways that characterize the 
time kinetics of the cellular response to specific components are very complex 
systems that interact with each other. Micro RNAs (miRs) are important non-
coding RNAs which regulate gene expression.  
The results showed that the treatment with Streptococcus thermophilus often 
induced different expression levels than the other probiotics, more similar to 
LPS. LPS treatment itself showed significant decreases in the expression of 
distinct genes that were not expected, especially after prestimulation with IL1β. 
Without prestimulation the only significant increases in gene expression could 
be seen after Streptococcus and LPS treatment. Within the expression 
detection of micro RNAs there was a clear trend that showed that miR7i was 
statistically significant decreased after every treatment. After the treatment with 
Lactobacillus acidophilus, every miR was decreased significantly. Taken 
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together no significant upregulation of micro RNA expression could be observed 
after 24 hours of treatment, although miR155 expression was increased after 
Streptococcus and Lactobacillus treatment. 
To conclude the findings, probiotics and LPS have the ability to alter the 
expression of inflammatory genes and micro RNAs in CACO2 cells. Whereas 
micro RNA expression presumably influenced inflammatory gene expression. 
Especially effects on already existing inflammatory processes could be shown. 
Further investigations are necessary to claim the impact of specific probiotics 
and LPS on the human immune system. 
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Zusammenfassung 
In dieser Arbeit wurde die veränderte Genexpression von Interleukin 6 (IL6), 
Tumor Nekrosis Faktorα (TNFα), Nuklear Faktor kappa B, Untereinheit p65 
(NFκBp65) und Peroxisom Proliferativer aktivierter Rezeptor γ (PPARγ) nach 
der Behandlung mit den Probiotika Lactobacillus acidophilus NCFM, 
Bifidobacterium lactis 420, Streptococcus thermophilus ST21 und mit 
Lipopolysacchariden (LPS) untersucht. All diese Stoffe wurden einerseits zu 
nicht vorstimulierten Zellen, anderseits zu Interleukin 1β (IL1β) vorstimulierten 
Zellen zugesetzt. Dieser Aufbau stellte sicher, dass auf der einen Seite die 
Auswirkungen der Probiotika und LPS auf die Zellen klar wurden und auf der 
anderen Seite ihr Einfluss auf entzündliche Vorgänge, die durch IL1β 
hervorgerufen wurden. Die Expression von miR7i, miR27b und miR155 wurde 
ebenfalls nach der Behandlung mit LPS, Lactobacillus acidophilus und 
Streptococcus thermophilus bestimmt. Es wurde das Colon Karzinom 
Zellsystem CACO2 verwendet. 
Epigenetik wird definiert als eine Veränderung in der Genexpression ohne 
Veränderungen in der DNA Sequenz. Verschiedene Nahrungsmittelinhaltsstoffe 
können die Genexpression verändern. Die Signaltransduktionswege, die die 
Zeitkinetik der zellulären Antwort auf spezifische Inhaltsstoffe bestimmen, sind 
komplex und interagieren auf verschieden Weisen miteinander. micro RNAs 
(miRs) sind wichtige nicht-kodierende RNAs, die die Genexpression regulieren.  
Die Ergebnisse zeigten, dass die Behandlung mit  Streptococcus thermophilus 
oft zu Expressionslevels führt, die sich von den anderen Probiotika 
unterscheiden. LPS zeigte, vor allem in IL1β vorstimulierten Zellen, ein 
unerwartetes Herabsenken der Expression von Genen. In nicht vorstimulierten 
Zellen, konnten nur nach LPS Behandlung signifikante Steigerungen in der 
Genexpression festgestellt werden. Die Expressionen der miRNAs zeigten 
einen klaren Trend, so konnte die miR7i durch alle Behandlungen statistisch 
signifikant gesenkt werden. Nach Behandlung mit Lactobacillus acidophilus war 
die Expression aller miRs signifikant gesunken. Es konnte nach Auswertung 
aller Ergebnisse keine Erhöhung der micro RNA Expression nach 24 Stunden 
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Behandlung festgestellt werden. Obwohl die miR155 Expression nach 
Streptococcus und Lactobacillus Behandlung erhöht war. 
Im Rahmen dieser Arbeit zeigten Probiotika und LPS die Fähigkeit in CACO2 
Zellen die Expression von entzündungs-spezifischen Genen zu verändern. 
Wobei die micro RNA Expression wahrscheinlich die Expression 
entzündungsspezifischer Gene beeinflusst. Die Veränderungen konnten 
insbesondere bei bereits vorhandenen entzündlichen Prozessen gezeigt 
werden.  
Weitere Studien sind notwendig um den Effekt von Probiotika und LPS auf das 
Immunsystem von Menschen klar nachweisen zu können. 
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Protocols 
RNeasy Mini Kit (Qiagen) 
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(04/2006)  
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Phusion RT-PCR Kit Finnzymes 
Protocol for cDNA synthesis 
  
Guidelines for reverse transcription 
• Use gloves and RNase-free plasticware to prevent RNase contamination. 
• Prepare premixes to avoid pipetting very small volumes. 
• Pipet all components on ice. 
• Reaction volume in cDNA synthesis is 20 µl. 
• Use up to 1 µg of RNA template. The minimum amount depends on 
both the template and the primers used. 
• Recommended primer amounts in a 20 µl reaction: 
- 100 ng oligo(dT) primers (can be increased up to 1 µg) or 
- 50 ng random primers (may require optimization) or 
- 5 pmol (2–10 pmol) gene-specific primers. 
Note: When determining the amount of RNA template, the expression 
level of the target RNA molecule should be considered, as it affects the 
subsequent PCR step. The volume of the cDNA reaction mixture used as 
a source for template in PCR should not exceed 10 % of the final PCR 
reaction volume. A high RNA concentration in the PCR may also inhibit 
the reaction. 
  
Protocol 
It is recommended that control reactions be performed in parallel with 
all experiments. Control RNA and primers are provided with the kit. The 
setup for controls is given in chapter 6. 
1. Thaw template RNA, 10x RT buffer, dNTPs and primers. Mix the 
individual solutions to assure homogeneity and centrifuge briefly 
before pipetting. 
2. Combine the following components in reaction tubes 
Template RNA x µl (up to 1 µg) 
10 mM dNTP mix 1 µl 
Oligo(dT) primer* 1 µl 
RNase-free H2O Add to 10 µl 
3. Incubate at 65°C for 5 minutes to predenature the RNA. 
4. Place the reaction tubes on ice and add to each tube 
10x RT buffer 2 µl 
RT enzyme mix 2 µl 
RNase-free H2O 6 µl 
5. Program a thermal cycler as outlined in Table 1. 
6. Place the tubes in the cycler and start the program. 
Table 1. Cycler protocol for cDNA synthesis. 
Step Temperature Time 
Primer extension 25°C 10 min 
cDNA synthesis 40°C 30 min 
Reaction termination 85°C 5 min 
Cooling of the sample 4°C Hold 
  
Primer extension 
The incubation for 10 minutes at 25°C extends oligo(dT) and random 
primers before the actual cDNA synthesis. Without the incubation at 
25°C, the primers may dissociate from the template when the temperature 
is increased. When using gene-specific primers, this extension step is 
not necessary. 
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cDNA synthesis 
Incubation at 40°C will work for most templates, but the incubation 
temperature can be optimized between 37–48°C, if necessary. Increasing 
the temperature can be helpful if the template has strong secondary 
structures. A higher temperature can also improve specificity if genespecific 
primers are used. Incubation above 48°C is not recommended. 
In most cases, incubation for 30 minutes is sufficient. If the target 
is located near the 5’ end of a long transcript and oligo(dT) priming is 
used, or if the target is rare, cDNA synthesis time can be extended up 
to 60 min. 
 
 Reaction termination 
The termination step at 85°C inactivates the M-MuLV RT. This prevents 
the reverse transcriptase from inhibiting the subsequent PCR reaction. 
Note: A separate RNase H treatment is not required. The cDNA can be 
directly used as a template in the subsequent PCR or stored at -20°C, if 
not used immediately. 
(April 2010) 
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QuantiMir RT Kit - Small RNA Quantitation System (System Biosciences)
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Appendix 
 
Experiments with CACO2 cells have also been done with Nano Silver. Nano 
Silver is becoming of interest in nutrition because it is already used in packaging 
material in the food industry. It has become an important substance because of 
its antibacterial characteristics. Another cause for the interest in this “new” 
substance is that Nano Silver is sold as food additive. It is also often a 
component of deodorants, room sprays, water cleaners, laundry detergents and 
wall paint. Although it is already widely used, there is not much known about its 
biological effects. (Miura and Shinohara 2009) 
The mechanism that makes Nano Silver toxic for bacteria depends on the ability 
of the ionic silver to bind to the negatively charged bacterial cell wall. 
Furthermore, Reactive Oxygen Species (ROS) are produced, followed by a de-
activation of cellular enzymes. Possible mechanisms for Nano Silver to increase 
the cytotoxic effect are: on the one hand attachment to cell membranes but also 
changes of the membrane permeability and intracellular accumulation of ROS 
on the other hand. (Miura and Shinohara 2009) 
Nano Silver is already discussed to have a pro-inflammatory impact on human 
cells, so that the objectives were the following: Proofing the inflammatory, 
cytotoxic and apoptotic effect of Nano Silver on CACO2 cells. This was done by 
stimulation of CACO2 cells with Nano Silver for 24 hours. Afterwards the mRNA 
level of the genes TNFα and IL6 as inflammatory genes and Caspase3 as 
apoptotic gene were measured. Additionally, a Trypanblue test was done to 
investigate the viability and cell survival after Nano Silver stimulation. Different 
concentrations were tested to proof the toxic potential of Nano Silver. 
CACO2 cells were grown in the already described medium. No IL1β was added, 
the concentrations of Nano Silver ranged from 0,01 μg/ml to 50 μg/ml. The used 
substance was Nano Silver: NM – 300 Silver, the size was <20nm, the 
concentration of the stock solution was 105 ppm, the particles were citrate 
coated so that they should not form aggregates.  
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The results showed a pro-inflammatory effect of Nano Silver. Especially at the 
concentration of 50 μg/ml, IL6 and TNFα were dramatically increased. (The 
control is 0). 
 
 
Figure  34 IL6 Expression after Nano Silver Treatment 
 
 
Figure  35 TNFα Expression after Nano Silver Treatment 
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The expression of the apoptotic gene Caspase 3 showed opposite expression 
levels: 
 
 
Figure  36 Caspase3 Expression after Nano Silver Treatment 
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The expression of inflammation specific micro RNAs also changed dramatically 
after Nano Silver stimulation: 
 
 
Figure  37 miR7i Expression after Nano Silver Treatment 
 
 
 
Figure  38 miR27b Expression after Nano Silver Treatment 
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Figure  39 miR155 Expression after Nano Silver Treatment 
 
 
 
Furthermore the Trypanblue test showed following results: 
 
Figure  40 Number of Cells after Nano Silver Treatment 
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Figure  41 Viability of Cells after Nano Silver Treatment 
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that shows an increasing Nano Silver concentration is followed by an increased 
concentration of mRNA of inflammatory genes. The viability and the number of 
cells decrease with higher concentrations. At a concentration of 50 μg/ml the 
viability nearly decreased to one half of the control. This concentration seems to 
be cytotoxic. The decreased expression of Caspase 3, miR7i, miR27b and 
miR155 at the concentration of 50 μg/ml are maybe the result of a decreased 
cell number, miRs could not be detected in samples with a low cell number in 
other experiments too. The results would point to an extreme apoptotic cell 
population. The cells that are left produce extremely elevated mRNA levels of 
inflammatory marker to either survive the inflammatory stress induced by Nano 
Silver stimulation or to initiate apoptosis too. 
Biological effects of Nano Silver are still not clear and have not already been 
tested enough to see a clear impact. It is very important to find out more about 
cytotoxicity, pro-inflammatory or anti-inflammatory effects of Nano Silver. 
Another point for discussion is that the concentration of Nano Silver in food 
additives is 50 mg/l, the same concentration that was found to be cytotoxic in 
this work. Nano Silver is an agent that is already widely used but it is not fully 
understood at the moment. 
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